Not yet recruiting
iSCIB1+ in Combination With Ipilimumab and Nivolumab as First-Line Treatment for Advanced Unresectable Melanoma
NCT07815574
- Conditions
- Advanced Melanoma, Melanoma, Melanoma (Skin Cancer), +13 more
- Locations
-
- University of Colorado Cancer Center Aurora, Colorado, United States
- Mount Vernon Cancer Centre London, United Kingdom